Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03503591 · ClinicalTrials.gov registry record
Study of the Hummingbird TTS™ Tympanostomy Tube System
A clinical trial, sponsored by Preceptis Medical.
- Completed
- Registry status
- 109
- Enrollment target
NCT03503591: Completed study, sponsored by Preceptis Medical.
NCT03503591 is a clinical trial that has completed, run by Preceptis Medical. The registered enrollment target is 109 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03503591 has completed, sponsored by Preceptis Medical.
- COMPLETED
- Registry status
- 109 participants
- Enrollment target
Study Summary
The objective of this study was continued commercial evaluation of the intraoperative safety and performance of the H-TTS for the placement of ventilation tubes in pediatric patients undergoing a tympanostomy procedure under moderate sedation and local anesthetic.
Primary Outcome
Percentage of procedures that require conversion from sedation to general anesthesia
Interventions
- DEVICE Hummingbird Tympanostomy Tube System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2016-01-29 |
| Est. Completion | 2021-08 |
What the finished NCT03503591 record still lists
NCT03503591 is an observational study that tracks outcomes without assigning an intervention. The registered 109 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Hummingbird Tympanostomy Tube System is the first listed.
NCT03503591 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03503591 about?
NCT03503591 is a clinical study titled "Study of the Hummingbird TTS™ Tympanostomy Tube System". The objective of this study was continued commercial evaluation of the intraoperative safety and performance of the H-TTS for the placement of ventilation tubes in pediatric patients undergoing a tympanostomy procedure under moderate sedation and local anesthetic.
What is the current status of trial NCT03503591?
This trial is currently completed. The enrollment target is 109 participants. The study started on 2016-01-29. Estimated completion is 2021-08.
What interventions are being tested in trial NCT03503591?
The interventions under investigation include: Hummingbird Tympanostomy Tube System (DEVICE).
Who is sponsoring clinical trial NCT03503591?
This trial is sponsored by Preceptis Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02421380 · 109 participants · NA
Characterization of Hyperpolarized Pyruvate MRI Reproducibility
- NCT04526600 · 109 participants · NA
Fidgeting and Attentional and Emotional Regulation in ADHD
- NCT04835584 · 109 participants · Phase 1
KRT-232 and TKI Study in Chronic Myeloid Leukemia
- NCT06626516 · 109 participants · Phase 1
Tebentafusp-tebn With LDT in Metastatic UM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI